Incidence and Severity of Residual Neuromuscular Blockade

PHASE4CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Residual Neuromuscular Blockade
Interventions
PROCEDURE

Standardized NMBD Management

The intervention phase will introduce a standardized research protocol that spells out NMBD management, including how muscle relaxant should be administered and monitored, and how reversal with neostigmine should be done.

Trial Locations (1)

98195

University of Washington Medical Center, Seattle

All Listed Sponsors
lead

University of Washington

OTHER

NCT02660398 - Incidence and Severity of Residual Neuromuscular Blockade | Biotech Hunter | Biotech Hunter